Published in J Diabetes Sci Technol on May 01, 2013
Freedom of speech and science: can companies force us to withdraw data they don't like? J Diabetes Sci Technol (2013) 0.75
Blood Glucose Test Strip Utilization Within Medicare. J Diabetes Sci Technol (2014) 0.75
System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol (2012) 3.22
Lot-to-lot variability of test strips and accuracy assessment of systems for self-monitoring of blood glucose according to ISO 15197. J Diabetes Sci Technol (2012) 2.76
Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers. J Diabetes Sci Technol (2013) 2.58
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
Blood glucose test strips: options to reduce usage. CMAJ (2009) 1.34
Self-monitoring of blood glucose in type 2 diabetes: recent studies. J Diabetes Sci Technol (2013) 1.11
Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med (2013) 6.64
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes (2004) 3.66
Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care (2008) 3.66
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther (2012) 2.46
The missing element of telemedicine for diabetes: decision support software. J Diabetes Sci Technol (2009) 1.83
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther (2013) 1.71
Time synching or time sinking? Diabetes Technol Ther (2005) 1.70
The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care (2004) 1.55
Using telemedicine to improve outcomes in diabetes--an emerging technology. J Diabetes Sci Technol (2009) 1.52
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol (2010) 1.48
Basal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go: a novel continuous subcutaneous infusion device. J Diabetes Sci Technol (2008) 1.46
Technical aspects of the Parkes error grid. J Diabetes Sci Technol (2013) 1.41
Second insulin pump safety meeting: summary report. J Diabetes Sci Technol (2010) 1.40
A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Diabetologia (2014) 1.38
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center. J Diabetes Sci Technol (2012) 1.35
A review of the security of insulin pump infusion systems. J Diabetes Sci Technol (2011) 1.34
Regulatory controversies surround blood glucose monitoring devices. J Diabetes Sci Technol (2010) 1.32
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care (2013) 1.32
Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther (2003) 1.24
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther (2011) 1.21
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care (2005) 1.19
Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther (2003) 1.16
New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly. J Diabetes Sci Technol (2008) 1.15
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther (2011) 1.14
The need for clinical accuracy guidelines for blood glucose monitors. J Diabetes Sci Technol (2012) 1.14
Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care (2003) 1.11
Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care (2005) 1.10
Non-invasive glucose monitoring in patients with Type 1 diabetes: a Multisensor system combining sensors for dielectric and optical characterisation of skin. Biosens Bioelectron (2009) 1.08
Biosimilar insulin and insulin antibodies. J Diabetes Sci Technol (2013) 1.08
Hypoglycemia warning signal and glucose sensors: requirements and concepts. Diabetes Technol Ther (2003) 1.08
Personalized medicine for diabetes. J Diabetes Sci Technol (2008) 1.05
Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3). J Diabetes Sci Technol (2007) 1.00
SMBG out of control: the need for educating patients about control solution. Diabetes Educ (2013) 0.99
Designing an artificial pancreas system to be compatible with other medical devices. J Diabetes Sci Technol (2008) 0.99
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care (2010) 0.99
Dose-response relationship of insulin glulisine in subjects with type 1 diabetes. Diabetes Care (2007) 0.99
Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther (2003) 0.98
The current status of bolus calculator decision-support software. J Diabetes Sci Technol (2012) 0.97
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol (2013) 0.97
The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Diabetes Technol Ther (2009) 0.96
Technology to treat hyperglycemia in trauma. J Diabetes Sci Technol (2007) 0.94
Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin. J Diabetes Sci Technol (2008) 0.93
Subcutaneous continuous glucose monitoring in severe burn patients. Crit Care Med (2007) 0.92
Quality Control of Insulins and Biosimilar Insulins: What Do We Know? J Diabetes Sci Technol (2016) 0.91
Assessing the analytical performance of systems for self-monitoring of blood glucose: concepts of performance evaluation and definition of metrological key terms. J Diabetes Sci Technol (2013) 0.90
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther (2014) 0.90
Point-of-Care Blood Glucose Meter Accuracy in the Hospital Setting. Diabetes Spectr (2014) 0.90
Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support. J Diabetes Sci Technol (2012) 0.89
Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care: response to Staten et al. Diabetes Care (2010) 0.89
Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors. J Diabetes Sci Technol (2008) 0.88
Twelve modern digital technologies that are transforming decision making for diabetes and all areas of health care. J Diabetes Sci Technol (2013) 0.88
Nonlinear metabolic effect of insulin across the blood glucose range in patients with type 1 diabetes mellitus. J Diabetes Sci Technol (2010) 0.88
Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same? J Diabetes Sci Technol (2011) 0.88
Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol (2013) 0.87
Improving the safety of blood glucose monitoring. J Diabetes Sci Technol (2011) 0.86
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. J Diabetes Sci Technol (2011) 0.86
Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial. PLoS One (2011) 0.84
Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study. Diabetes Metab Res Rev (2005) 0.83
Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time. Diabetes Technol Ther (2013) 0.83
System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions. Diabetes Technol Ther (2013) 0.83
A rapid and reliable semiautomated method for measurement of total abdominal fat volumes using magnetic resonance imaging. Magn Reson Imaging (2003) 0.82
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PLoS One (2012) 0.82
Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5). Arzneimittelforschung (2007) 0.82
Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol (2009) 0.82
Spending for diabetes drugs is increasing in the United States. J Diabetes Sci Technol (2008) 0.81
Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion. J Diabetes Sci Technol (2010) 0.81
Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c. J Diabetes Sci Technol (2007) 0.81
Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes. Diabetes Technol Ther (2004) 0.81
Biphasic insulin aspart 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapy. Diabetes Care (2009) 0.81
Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes. J Diabetes Sci Technol (2008) 0.80
The increasing incidence of diabetes in the 21st century. J Diabetes Sci Technol (2009) 0.80
Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: a never ending story? J Diabetes Sci Technol (2007) 0.80
(Analytical) accuracy of blood glucose meters and patients: how do they come together? J Diabetes Sci Technol (2013) 0.79
United Kingdom prospective diabetes study follow-up studies establish a legacy effect of therapy for hyperglycemia but not hypertension. J Diabetes Sci Technol (2008) 0.79
Hospital diabetes: why quality of care matters to both patients and hospitals. J Diabetes Sci Technol (2011) 0.78
Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol. Diabetes Technol Ther (2004) 0.78
The need for a glycemia modeling comparison workshop to facilitate development of an artificial pancreas. J Diabetes Sci Technol (2010) 0.78
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects. Metabolism (2004) 0.78
The benefits of implanted glucose sensors. J Diabetes Sci Technol (2007) 0.78
The need for performance standards for continuous glucose monitors. J Diabetes Sci Technol (2007) 0.78
A sweetened beverage tax is needed to combat the obesity epidemicas well as related absenteeism and presenteeism. J Diabetes Sci Technol (2009) 0.78
Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes. Diabetes Care (2002) 0.78
The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). PLoS One (2013) 0.77
AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability. Diabetes Care (2007) 0.77
The beneficial effects of a Paleolithic diet on type 2 diabetes and other risk factors for cardiovascular disease. J Diabetes Sci Technol (2009) 0.77
The diabetes technologist: a practical solution in dealing with technology in everyday practice? J Diabetes Sci Technol (2012) 0.77
First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test. Diabetes Technol Ther (2010) 0.76
Further development of artificial pancreas: blocked by patents? J Diabetes Sci Technol (2008) 0.76
Microdialysis of interstitial fluid for continuous glucose measurement. Diabetes Technol Ther (2003) 0.76
Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose. Diabetes Technol Ther (2009) 0.76
Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring study. J Diabetes Sci Technol (2012) 0.76
A 4-h hyperglycaemic excursion induces rapid and slow changes in major electrolytes in blood in healthy human subjects. Acta Diabetol (2011) 0.76
Business and economics of diabetes. J Diabetes Sci Technol (2008) 0.76
AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics. Diabetes Technol Ther (2009) 0.76
Future of diabetes-technology: certificate of competency for insulin pumps and continuous glucose monitors. J Diabetes Sci Technol (2012) 0.76
Biosimilar insulins: how will this story evolve? Diabetes Technol Ther (2012) 0.75